US Stock MarketDetailed Quotes

PHIO Phio Pharmaceuticals

Watchlist
  • 2.2100
  • -0.0200-0.90%
Close Nov 15 16:00 ET
  • 2.2100
  • 0.00000.00%
Post 20:01 ET
2.33MMarket Cap-226P/E (TTM)

Phio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-24.85%1.91M
-38.67%2.21M
-6.67%10.7M
-35.05%1.77M
-22.26%2.78M
1.03%2.55M
36.44%3.6M
-15.17%11.46M
-20.87%2.73M
-4.49%3.57M
Selling and administrative expenses
-9.97%1.05M
-27.72%1.06M
-1.89%4.37M
-31.36%766K
-8.94%968K
-4.35%1.16M
39.28%1.47M
-3.78%4.45M
-8.90%1.12M
-0.28%1.06M
-General and administrative expense
-9.97%1.05M
-27.72%1.06M
-1.89%4.37M
-31.36%766K
-8.94%968K
-4.35%1.16M
39.28%1.47M
-3.78%4.45M
-8.90%1.12M
-0.28%1.06M
Research and development costs
-37.38%866K
-46.20%1.15M
-9.70%6.33M
-37.61%1.01M
-27.91%1.81M
6.06%1.38M
34.55%2.13M
-21.09%7.01M
-27.46%1.61M
-6.17%2.51M
Operating profit
24.85%-1.91M
38.67%-2.21M
6.67%-10.7M
35.05%-1.77M
22.26%-2.78M
-1.03%-2.55M
-36.44%-3.6M
15.17%-11.46M
20.87%-2.73M
4.49%-3.57M
Net non-operating interest income expense
Other net income (expense)
3,500.00%68K
55K
-611.11%-128K
-12,100.00%-122K
20.00%-4K
80.00%-2K
-108.04%-18K
0.00%-1K
-66.67%-5K
Special income (charges)
----
----
---126K
----
----
----
----
--0
----
----
-Less:Impairment of capital assets
----
----
--126K
----
----
----
----
--0
----
----
Other non- operating income (expenses)
3,500.00%68K
--55K
88.89%-2K
500.00%4K
20.00%-4K
80.00%-2K
----
-108.04%-18K
0.00%-1K
-66.67%-5K
Income before tax
27.58%-1.85M
40.20%-2.15M
5.70%-10.83M
30.61%-1.9M
22.26%-2.78M
-0.71%-2.55M
-36.34%-3.6M
13.60%-11.48M
20.86%-2.73M
4.44%-3.58M
Income tax
Net income
27.58%-1.85M
40.20%-2.15M
5.70%-10.83M
30.61%-1.9M
22.26%-2.78M
-0.71%-2.55M
-36.34%-3.6M
13.60%-11.48M
20.86%-2.73M
4.44%-3.58M
Net income continuous Operations
27.58%-1.85M
40.20%-2.15M
5.70%-10.83M
30.61%-1.9M
22.26%-2.78M
-0.71%-2.55M
-36.34%-3.6M
13.60%-11.48M
20.86%-2.73M
4.44%-3.58M
Minority interest income
Net income attributable to the parent company
27.58%-1.85M
40.20%-2.15M
5.70%-10.83M
30.61%-1.9M
22.26%-2.78M
-0.71%-2.55M
-36.34%-3.6M
13.60%-11.48M
20.86%-2.73M
4.44%-3.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
27.58%-1.85M
40.20%-2.15M
5.70%-10.83M
30.61%-1.9M
22.26%-2.78M
-0.71%-2.55M
-36.34%-3.6M
13.60%-11.48M
20.86%-2.73M
4.44%-3.58M
Basic earnings per share
72.72%-3.62
85.08%-4.23
48.51%-46.8
92.92%-1.53
63.69%-10.26
33.58%-13.27
-34.62%-28.35
18.71%-90.9
21.70%-21.6
6.55%-28.26
Diluted earnings per share
72.72%-3.62
85.08%-4.23
48.51%-46.8
92.92%-1.53
63.69%-10.26
33.58%-13.27
-34.62%-28.35
18.71%-90.9
21.70%-21.6
6.55%-28.26
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -24.85%1.91M-38.67%2.21M-6.67%10.7M-35.05%1.77M-22.26%2.78M1.03%2.55M36.44%3.6M-15.17%11.46M-20.87%2.73M-4.49%3.57M
Selling and administrative expenses -9.97%1.05M-27.72%1.06M-1.89%4.37M-31.36%766K-8.94%968K-4.35%1.16M39.28%1.47M-3.78%4.45M-8.90%1.12M-0.28%1.06M
-General and administrative expense -9.97%1.05M-27.72%1.06M-1.89%4.37M-31.36%766K-8.94%968K-4.35%1.16M39.28%1.47M-3.78%4.45M-8.90%1.12M-0.28%1.06M
Research and development costs -37.38%866K-46.20%1.15M-9.70%6.33M-37.61%1.01M-27.91%1.81M6.06%1.38M34.55%2.13M-21.09%7.01M-27.46%1.61M-6.17%2.51M
Operating profit 24.85%-1.91M38.67%-2.21M6.67%-10.7M35.05%-1.77M22.26%-2.78M-1.03%-2.55M-36.44%-3.6M15.17%-11.46M20.87%-2.73M4.49%-3.57M
Net non-operating interest income expense
Other net income (expense) 3,500.00%68K55K-611.11%-128K-12,100.00%-122K20.00%-4K80.00%-2K-108.04%-18K0.00%-1K-66.67%-5K
Special income (charges) -----------126K------------------0--------
-Less:Impairment of capital assets ----------126K------------------0--------
Other non- operating income (expenses) 3,500.00%68K--55K88.89%-2K500.00%4K20.00%-4K80.00%-2K-----108.04%-18K0.00%-1K-66.67%-5K
Income before tax 27.58%-1.85M40.20%-2.15M5.70%-10.83M30.61%-1.9M22.26%-2.78M-0.71%-2.55M-36.34%-3.6M13.60%-11.48M20.86%-2.73M4.44%-3.58M
Income tax
Net income 27.58%-1.85M40.20%-2.15M5.70%-10.83M30.61%-1.9M22.26%-2.78M-0.71%-2.55M-36.34%-3.6M13.60%-11.48M20.86%-2.73M4.44%-3.58M
Net income continuous Operations 27.58%-1.85M40.20%-2.15M5.70%-10.83M30.61%-1.9M22.26%-2.78M-0.71%-2.55M-36.34%-3.6M13.60%-11.48M20.86%-2.73M4.44%-3.58M
Minority interest income
Net income attributable to the parent company 27.58%-1.85M40.20%-2.15M5.70%-10.83M30.61%-1.9M22.26%-2.78M-0.71%-2.55M-36.34%-3.6M13.60%-11.48M20.86%-2.73M4.44%-3.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 27.58%-1.85M40.20%-2.15M5.70%-10.83M30.61%-1.9M22.26%-2.78M-0.71%-2.55M-36.34%-3.6M13.60%-11.48M20.86%-2.73M4.44%-3.58M
Basic earnings per share 72.72%-3.6285.08%-4.2348.51%-46.892.92%-1.5363.69%-10.2633.58%-13.27-34.62%-28.3518.71%-90.921.70%-21.66.55%-28.26
Diluted earnings per share 72.72%-3.6285.08%-4.2348.51%-46.892.92%-1.5363.69%-10.2633.58%-13.27-34.62%-28.3518.71%-90.921.70%-21.66.55%-28.26
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data